Latest healthtech and biotech deals
The largest from last week:
🇮🇱 Israeli AI-driven imaging platform AIDOC announced that it raised a $110M Series D funding to enable hospitals to tackle the post-pandemic scenario of shortages and supply costs in the post-pandemic system. The investment is to be used to expand the company’s AI capabilities.
🇨🇳 Fourth-generation sequencing technology company Axbio completed a Series B funding round worth nearly $100M. The fund will be used to optimize the sequencing technology, build the production base, and pave the way for commercialization.
🇺🇸 Aerin Medical, a company dedicated to providing ear, nose and throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, has recently closed $60M equity financing. The company intends to use the proceeds to scale commercialization and expand market access to meet the demand from physicians and their patients.
🇺🇸 Medical device maker, MicroTransponder, wrapped up a $53M Series E funding round. The company said it will use the capital to commercialize its Vivistim vagus nerve stimulation system, an implantable device that aims to improve hand and arm mobility in stroke patients.
Other notable deals from around the globe:
🇺🇸 Sling Therapeutics, a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED), has raised a $35M Series A financing. The funds will support a Phase 2b clinical trial evaluating the company's investigational drug, linsitinib, for the treatment of TED.
🇺🇸 Oma Fertility, a full-service fertility clinic that brings top lab design and technology to in-house treatments like IUI and IVF, raised $37.5M in an undisclosed funding round.
🇺🇸 Abacus Insights, a leader in data management and interoperability solutions for healthcare payers, raised a $28M Series C round.
Read up on all the latest health deals in Dealroom.co
%20(1).png?upscale=true&width=1200&upscale=true&name=unnamed%20(7)%20(1).png)
